Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S., M.D. (Gastroenterology), M.R.C.P (UK), ESEGH (UK)
Internal Medicine Specialist
M.B.B.S, MRCP (UK)
Nephrologist
MBBS, FCPS (Medicine), FCPS (Nephrology)
Neurologist
MBBS, FCPS (Medicine), FCPS (Neurology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.B.B.S., MRCP
Internal Medicine Specialist
M.B.B.S., MRCPI
Pediatric Gastroenterologist
M.B.B.S., F.C.P.S., F.C.P.S Gastroenterologist and Hepatologist and Nutritionist
Pediatric Gastroenterologist
M.B.B.S., F.C.P.S., F.C.P.S Gastroenterologist and Hepatologist and Nutritionist
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures